Vertos Medical

OverviewSuggest Edit

Vertos Medical is a medical device company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS). The Company's proprietary technologies include mild®, which offers a safe, outpatient, minimally invasive, fluoroscopically guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. Clinical trials have shown that mild® can help LSS patients stand longer and walk farther with less pain.

TypePrivate
Founded2005
HQAliso Viejo, CA, US
Websitevertosmed.com

Latest Updates

Employees (est.) (Jun 2021)105
Cybersecurity ratingAMore

Key People/Management at Vertos Medical

David P. Lalor

David P. Lalor

Vice President of Operations/Research & Development
Rebecca Colbert

Rebecca Colbert

Chief Financial Officer and Chief Operating Officer
Eric Wichems

Eric Wichems

President, Chief Executive Officer & Director
Amy Scott

Amy Scott

Vice President of Marketing and Physician Education
Stephen E. Paul

Stephen E. Paul

Vice President of Sales
Karen Davis

Karen Davis

Vice President of Clinical Research
Show more

Vertos Medical Office Locations

Vertos Medical has an office in Aliso Viejo
Aliso Viejo, CA, US (HQ)
95 Enterprise #325
Show all (1)

Vertos Medical Financials and Metrics

Summary Metrics

Founding Date

2005

Vertos Medical total Funding

$97.4 m

Vertos Medical latest funding size

$28 m

Time since last funding

4 years ago

Vertos Medical investors

Vertos Medical's latest funding round in June 2017 was reported to be $28 m. In total, Vertos Medical has raised $97.4 m
Show all financial metrics

Vertos Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Vertos Medical Online and Social Media Presence

Embed Graph

Vertos Medical News and Updates

Vertos Medical Announces ASC Reimbursement Increase for the mild® Procedure

ALISO VIEJO, Calif., Dec. 8, 2020 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), today announced that the Centers for Medicare and Medicaid Services (CMS) has increased Ambulatory Surgery...

Vertos Medical Announces MILD® Procedure Long-term Safety and Efficacy Data

ALISO VIEJO, Calif., Sept. 11, 2018 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), today announced the publication of two-year data from a Centers for Medicare & Medicaid Services...

Vertos Medical Blogs

Objective Real-World Outcomes of Patients Suffering from Painful Neurogenic Claudication Treated with the mild® Procedure: Interim 6-Month Report of a Randomized Controlled Trial

A prospective randomized controlled trial that evaluates patients treated with the  Procedure for lumbar spinal stenosis (LSS) plus conventional medical management (CMM), compared to those treated with CMM alone. Follow-up includes 6-month, 1-year and 2-year assessments, with 1-year being primary. T…

Alternatives to Back Surgery

Patients with back pain caused by lumbar spinal stenosis (LSS) can often feel like they have only two options. They feel stuck between minor relief from over-the-counter pain medication, physical therapy, and chiropractic care, and more promising relief from invasive, costly back surgery. The good n…

New Study Demonstrates mild® Procedure Five-Year Durability

88% of Patients Avoid Surgical Lumbar Decompression for at Least Five Years After Receiving the Procedure  ALISO VIEJO, Calif. — Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), announced the results today of an independe…

Functional and Patient-Reported Outcomes in Symptomatic Lumbar Spinal Stenosis Following Percutaneous Decompression

In this single-site, 40-patient study, consecutive LSS patients presenting with neurogenic claudication were treated with percutaneous lumbar decompression. 1-year post-treatment, this prospective study demonstrated statistically significant improvement in pain (VAS improvement of 3.5 points), stand…

The Durability of Minimally Invasive Lumbar Decompression Procedure in Patients with Symptomatic Lumbar Spinal Stenosis: Long Term Follow-Up

A retrospective longitudinal observational cohort study that examines the long-term durability of the Procedure through 5-year follow-up. The analysis indicates that , a treatment for lumbar spinal stenosis (LSS) patients with hypertrophic ligamentum flavum, significantly decreased the need for surg…

5-Year Study Demonstrates 88% of mild® Patients Avoided Surgical Decompression For At Least 5 Years While Experiencing Significant Symptom Relief

The post 5-Year Study Demonstrates 88% of mild® Patients Avoided Surgical Decompression For At Least 5 Years While Experiencing Significant Symptom Relief appeared first on Vertos Medical.
Show more

Vertos Medical Frequently Asked Questions

  • When was Vertos Medical founded?

    Vertos Medical was founded in 2005.

  • Who are Vertos Medical key executives?

    Vertos Medical's key executives are David P. Lalor, Rebecca Colbert and Eric Wichems.

  • How many employees does Vertos Medical have?

    Vertos Medical has 105 employees.

  • Who are Vertos Medical competitors?

    Competitors of Vertos Medical include Allied Healthcare Products, ALung Technologies and Advanced Medical Solutions Group.

  • Where is Vertos Medical headquarters?

    Vertos Medical headquarters is located at 95 Enterprise #325, Aliso Viejo.

  • Where are Vertos Medical offices?

    Vertos Medical has an office in Aliso Viejo.

  • How many offices does Vertos Medical have?

    Vertos Medical has 1 office.